Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Expert Opinion on Pharmacotherapy|November 20, 2022
Imlifidase therapy: exploring its clinical usesLionel Rostaing, Johan Noble, Paolo Malvezzi, et al.Expert Review of Clinical Immunology|May 15, 2018
Advagraf® with or without an induction therapy for de novo kidney-transplant recipientsJohan Noble, Thomas Jouve, Lionel Rostaing, et al.Transplantation|August 8, 2022
Desensitization in Crossmatch-positive Kidney Transplant CandidatesJohan Noble, Thomas Jouve, Paolo Malvezzi, et al.Expert Review of Clinical Pharmacology|May 22, 2018
Tailoring tacrolimus therapy in kidney transplantationThomas Jouve, Johan Noble, Lionel Rostaing, et al.Best Practice & Research. Clinical Gastroenterology|December 7, 2021
Adverse effects of immunosuppression after liver transplantationJohan Noble, Florian Terrec, Paolo Malvezzi, et al.Expert Review of Gastroenterology & Hepatology|October 2, 2018
Renal complications of liver diseasesJohan Noble, Thomas Jouve, Paolo Malvezzi, et al.Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 5, 2018
Desensitization in the Setting of HLA-Incompatible Kidney TransplantPaolo Malvezzi, Thomas Jouve, Johan Noble, et al.Expert Review of Clinical Immunology|January 25, 2019
Belatacept in kidney transplantation and its limitationsJohan Noble, Thomas Jouve, Bénédicte Janbon, et al.Journal of Personalized Medicine|December 23, 2023
Adverse Drug Events after Kidney TransplantationLionel Rostaing, Thomas Jouve, Florian Terrec, et al.Expert Review of Clinical Pharmacology|November 16, 2020
pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppressionEloi Chevallier, Thomas Jouve, Lionel Rostaing, et al.Pageof 12